Get Ready to Feast on the Latest Clinical Data from Carmot Therapeutics: Fighting Obesity and Diabetes at the 83rd American Diabetes Association Scientific Sessions! Description: A presentation on 4-week weight loss data from CT-388, a once weekly, dual GLP-1/GIP receptor modulator being developed for obese patients with and without type 2 diabetes. Two presentations on…

Achieved Ninth Consecutive Quarter of Positive Adjusted EBITDA Shareholder Approval for Strategic Arrangement with Canopy and Canopy USA Gained Access to Additional Funding Through Amendments to Credit Facility NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF), a vertically integrated, multi-state operator of…

Lifecore Biomedical Sets Third Quarter 2023 Earnings Conference Call for June 1, 2023 at 7:30 a.m. CT CHASKA, Minn., May 22, 2023 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will host a conference call to discuss fiscal 2023 third…

Processa Pharmaceuticals to Participate in a Panel on Interaction with the FDA at the World Orphan Expo HANOVER, MD, May 22, 2023 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for…

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Stem, Inc. f/k/a Star Peak Energy Transition… New York, May 21, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Stem, Inc. (“Stem” or the “Company”) f/k/a Star Peak Energy Transition Corp. (“STPK”) (NYSE: STEM;…